Skip to main content

Table 2 Inhalation parameters before enhanced training

From: Inhalation characteristics of asthma patients, COPD patients and healthy volunteers with the Spiromax® and Turbuhaler® devices: a randomised, cross-over study

 

Children with asthma (n = 23)

Adolescents with asthma (n = 27)

Adults with asthma (n = 50)

Adults with COPD (n = 50)

Healthy adults (n = 50)

Spiromax

PIF, L/min

69.5

67.9

74.4

57.5

85.0

(17.2)

(15.1)

(18.1)

(21.0)

(13.6)

Max ΔP, kPa

5.0

4.7*

5.7*

3.7

7.3

(2.4)

(2.2)

(2.6)

(2.7)

(2.3)

ACC, kPa/s

13.6

12.1

15.6

11.0*

15.9*

(11.8)

(8.8)

(15.7)

(12.8)

(13.5)

Inhalation volume, L

1.50

2.03

2.39

1.82

2.98*

(0.6)

(0.81)

(1.03)

(0.88)

(1.02)

Turbuhaler

PIF, L/min

58.5

57.8

65.4

50.1

78.0

(14.7)

(13.4)

(17.5)

(16.2)

(11.8)

Max ΔP, kPa

3.9

3.9

5.1

3.1

7.0

(2.0)

(1.8)

(2.6)

(2.0)

(2.1)

ACC, kPa/s

10.2

11.4

13.0

8.4

12.8

(7.7)

(7.2)

(12.1)

(9.5)

(9.6)

Inhalation volume, L

1.25

1.68

2.13

1.58

2.80

(0.57)

(0.74)

(1.01)

(0.69)

(0.92)

  1. Data shown are mean (standard deviation). *p < 0.05 vs Turbuhaler; p < 0.01 vs Turbuhaler; p ≤ 0.0001 vs Turbuhaler.